582 related articles for article (PubMed ID: 21947761)
1. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.
Fernandez-Fernandez A; Manchanda R; McGoron AJ
Appl Biochem Biotechnol; 2011 Dec; 165(7-8):1628-51. PubMed ID: 21947761
[TBL] [Abstract][Full Text] [Related]
2. Nanosensors for early cancer detection and for therapeutic drug monitoring.
Salvati E; Stellacci F; Krol S
Nanomedicine (Lond); 2015; 10(23):3495-512. PubMed ID: 26606949
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles Design for Theranostic Approach in Cancer Disease.
Carrese B; Sanità G; Lamberti A
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230578
[TBL] [Abstract][Full Text] [Related]
5. Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery.
Sun D; Chen J; Wang Y; Ji H; Peng R; Jin L; Wu W
Theranostics; 2019; 9(23):6885-6900. PubMed ID: 31660075
[TBL] [Abstract][Full Text] [Related]
6. The Advancing Role of Nanocomposites in Cancer Diagnosis and Treatment.
Andoh V; Ocansey DKW; Naveed H; Wang N; Chen L; Chen K; Mao F
Int J Nanomedicine; 2024; 19():6099-6126. PubMed ID: 38911500
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology platforms and physiological challenges for cancer therapeutics.
Kim KY
Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
[TBL] [Abstract][Full Text] [Related]
8. Interlocked systems in nanomedicine.
Ornelas-Megiatto C; Becher TB; Megiatto JD
Curr Top Med Chem; 2015; 15(13):1236-56. PubMed ID: 25858133
[TBL] [Abstract][Full Text] [Related]
9. Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives.
Tang L; Li J; Pan T; Yin Y; Mei Y; Xiao Q; Wang R; Yan Z; Wang W
Theranostics; 2022; 12(5):2290-2321. PubMed ID: 35265211
[TBL] [Abstract][Full Text] [Related]
10. The upcoming field of theranostic nanomedicine: an overview.
Prabhu P; Patravale V
J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
[TBL] [Abstract][Full Text] [Related]
11. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional nanomedicine platforms for cancer therapy.
Zhang H
J Nanosci Nanotechnol; 2012 May; 12(5):4012-8. PubMed ID: 22852341
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK
Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
15. Hybrid Nanoplatforms Comprising Organic Nanocompartments Encapsulating Inorganic Nanoparticles for Enhanced Drug Delivery and Bioimaging Applications.
Yanar F; Carugo D; Zhang X
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570666
[TBL] [Abstract][Full Text] [Related]
16. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
17. Design of multifunctional nanocarriers for delivery of anti-cancer therapy.
Mehra NK; Jain K; Jain NK
Curr Pharm Des; 2015; 21(42):6157-64. PubMed ID: 26503145
[TBL] [Abstract][Full Text] [Related]
18. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
Raj R; Mongia P; Kumar Sahu S; Ram A
Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
[TBL] [Abstract][Full Text] [Related]
19. Engineered Polymer-Based Nanomaterials for Diagnostic, Therapeutic and Theranostic Applications.
Parisi OI; Scrivano L; Sinicropi MS; Picci N; Puoci F
Mini Rev Med Chem; 2016; 16(9):754-61. PubMed ID: 26156541
[TBL] [Abstract][Full Text] [Related]
20. Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect.
Sajja HK; East MP; Mao H; Wang YA; Nie S; Yang L
Curr Drug Discov Technol; 2009 Mar; 6(1):43-51. PubMed ID: 19275541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
